Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The EV-202 study record is available with its trial details, participant eligibility and locations, outcome measures, and reported results and publications. It also includes study documents and information on sharing participant-level data.
    Difference
    100%
    Check dated 2026-11-09T13:24:14.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T13:25:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:41:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T13:50:53.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error screen, indicating restricted access. It also shows a minimal header/footer with a Home link and a revision note (Revision: v3.7.0).
    Difference
    23%
    Check dated 2026-09-21T22:57:37.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.